Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Wireless Sweat Patch Could Be Used as Diagnostic Test for Cystic Fibrosis

By LabMedica International staff writers
Posted on 21 Aug 2025

Cystic fibrosis (CF) is a genetic disease that causes excessive mucus to accumulate in the lungs, impairs digestion, and can affect multiple organs. More...

More than 40,000 children and adults in the U.S. currently live with the disease, which is progressive and often results in early mortality. While treatments exist to improve quality of life, optimizing the use of new drugs outside clinical settings remains a challenge. A new wearable device now offers a way to monitor CF patients more effectively and provide real-time insights into treatment efficacy.

Developed by researchers from Northwestern Medicine (Chicago, IL, USA) in collaboration with spinout company Epicore Biosystems (Cambridge, MA, USA), the CF patch is a wireless sticker-like device that measures biomarkers in sweat. The patch is worn on the wrist and includes two channels: one for measuring sweat volume and another for measuring sweat chloride, the key diagnostic marker of CF. Physicians capture an image of the patch using a smartphone or tablet, and color changes are analyzed to provide data comparable in accuracy to laboratory-based testing.

In a study published in the Proceedings of the National Academy of Sciences, researchers evaluated the patch’s accuracy against the gold-standard chloride sweat test. To test feasibility, 20 adults with cystic fibrosis and seven healthy controls completed both a clinic-based chloride sweat test and five remote exercise sessions over 14 days while wearing the device. Researchers found that the CF patch measured sweat chloride as effectively as tests done in specialized laboratories.

These findings demonstrate that the wearable microfluidic sweat patch can deliver accurate, remote monitoring of sweat chloride in individuals with CF. Such technology could optimize the use of CFTR (cystic fibrosis transmembrane conductance regulator) modulator drugs, which improve protein function and disease trajectory, by offering consistent data on treatment effectiveness. The next phase will assess whether the device can guide clinical decision-making more directly in patient care.

Going forward, the patch could expand CF screening and monitoring in rural and under-resourced areas with limited access to diagnostic labs. By providing reliable results outside clinical environments, the device has the potential to expedite diagnosis and improve long-term disease management.

“We wanted to see how accurate our CF patch was relative to the gold standard, whether we could do it remotely at home, and then also see how consistent the sweat chloride is in response to the medications (i.e., CFTR modulators),” said Manu Jain, MD, senior author of the study. “Potentially this could be used as a screening or diagnostic test in parts of the country where sweat testing is not readily available and could expedite the diagnosis of cystic fibrosis.”

Related Links:
Northwestern Medicine
Epicore Biosystems


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.